More Information Coming Soon
Future Home of Belgravia Capital International

About Belgravia Capital

Belgravia Capital International Inc. is focused on three core business divisions: Incubator, Investments, and Royalty & Management Services. The Incubator division provides capital to support the development of early stage companies in the Biotech/Healthcare, Technology, Resources and Medical sectors. Belgravia Holdings, the Investments division, invests in various private and public companies with a focus on value. Belgravia Royalty & Management Services has a royalty and fee income model. Further, the cash and investment asset base provides capital to support international expansion on a selective basis.

Latest News

August 7, 2018
BELGRAVIA Intends to Replace the Board of Tartisan Nickel for Failure to Perform

July 18, 2018
BELGRAVIA corporate update

June 18, 2018
BELGRAVIA Dermatology Completes Identification of Initial Drug Targets Within the Skin Endocannabinoid System and Also Identifies Bio Markers for Pre Clinical Work in Acne

May 30, 2018
BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica

May 11, 2018
BELGRAVIA Completes Transition Of ICP Organics To Dermatology Product Development, Renames ICP Organics To Belgravia Dermatology Inc., And Appoints Sidney Himmel Director Of Belgravia Dermatology

April 27, 2018
BELGRAVIA announces results of Annual Meeting

April 18, 2018
Belgravia Appoints Dr. Sam Hanna Chief Medical Officer Of Cannabis Dermatology Division

March 12, 2018
BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee

February 28, 2018
BELGRAVIA CAPITAL signs Binding Letter of Intent with R&D Pharma Corp., a developer of a vertically integrated medicinal cannabis business in Jamaica, to invest Canadian $1,000,000.

January 25, 2018
BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry

January 12, 2018
BELGRAVIA CAPITAL INTERNATIONAL announces closing of private placement

January 10, 2018
BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments

January 4, 2018
BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.

January 3, 2018
BELGRAVIA CAPITAL INTERNATIONAL moves to build fully-owned subsidiary in Blockchain and Cannabis Industry

December 5, 2017
BELGRAVIA CAPITAL Corporate Update

November 22, 2017
IC Potash announces trading date on Canadian Securities Exchange under new name ‘Belgravia Capital International’

November 20, 2017
IC Potash provides update on listing on Canadian Stock Exchange

November 7, 2017
IC Potash announces pending move of trading venue to Canadian Securities Exchange

November 6, 2017
IC Potash announces expanded ICP Organics development strategy to include value-added cannabis industry products and services, including permissioned and private blockchain technologies

Annual Meeting 2018

View Annual and Special Meeting Materials

Financials

Q2 2018 Financial Statements

Q2 2018 Management’s Discussion and Analysis

Q1 2018 Financial Statements

Q1 2018 Management’s Discussion and Analysis

2017 Annual Audited Financial Statements

2017 Annual Management’s Discussion and Analysis

Contact

Telephone & Email

Jason Batista: + 1 416 579 6850
Jbatista@blgv.ca

Address

Belgravia Capital International
Administration Department
#3-3185 Via Centrale
Kelowna, BC V1V 2A7